Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.
NCI Director Kimryn Rathmell shared advice for the next generation of cancer researchers with members of the AACR Associate...
A special collection of commentaries in the AACR journal Cancer Discovery offers innovative ideas from leading Chinese researchers.
New research into potential causes of gastric cancer is looking beyond H. pylori to other bacteria within the gastric...
New advances in our understanding of cancer cachexia may provide hope for patients with pancreatic cancer.
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
A recent study on the prevalence of cancer across different vertebrate species may provide insights into cancer mechanisms in...
At the AACR Conference on the Science of Cancer Health Disparities, researchers shared results from interventions designed to help...
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of...
This Halloween edition features ghostly transparent mice, parasites to deliver drugs to the brain, stealing from the dead, and...